African country: Liberia said it would be the first African country to receive the drug, known as ZMapp. However, it will only be used on two doctors who have given their consent. The manufacturer, a San Diego biopharmaceutical firm Mapp, said that a delivery to an unnamed West African country had exhausted its supply, which is thought to have amounted only to around 10 doses. There is no cure for Ebola, but some victims do survive, according to The Independent. Efforts to combat the disease with untested medicine could in effect become the biggest ever clinical trial of drugs to combat Ebola. The rarity of the disease, and the fact it has only ever affected poor African countries, means there is a paucity of clinical evidence on effective treatments and The WHOs decision, a reflection of the unprecedented scale of the crisis, means that an experimental serum, which has already been used on three Ebola patients two Americans and a Spaniard will be dispatched to affected countries. However, the US manufacturer said that its very limited stock of the drug had already run out, and that it would take months to develop more. The WHOs ethics panel said that there was a moral obligation for health authorities to collect and share data on the effectiveness of experimental drugs deployed in the current outbreak.
(news.financializer.com). As
reported in the news.
Tagged under San Diego biopharmaceutical, Ebola topics.